Skip to main content
  • Long-Term Data Back SAVR in Younger and Low-Risk Patients

    Long-term registry data show that 85% of surgical aortic valve replacement (SAVR) patients receiving bioprostheses have low surgical risk, with “substantial” survival – especially in younger, low-risk patients.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details